Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

May 01, 2023

Axonics Reports First Quarter 2023 Financial Results

Apr 25, 2023

Axonics to Participate in Upcoming Investor Conferences

Apr 24, 2023

Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation

Apr 10, 2023

Axonics to Report First Quarter 2023 Financial Results on May 1

Mar 29, 2023

Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas

Mar 07, 2023

Axonics to Participate in the SUFU 2023 Winter Meeting

Mar 01, 2023

Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Feb 08, 2023

Axonics to Report Fourth Quarter 2022 Financial Results on March 1

Jan 31, 2023

Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Jan 11, 2023

Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

© 2020-2023 Axonics, Inc.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap